↓ Skip to main content

Folic Acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, December 2011
Altmetric Badge

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
12 Mendeley
Title
Folic Acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile
Published in
Journal of Experimental & Clinical Cancer Research, December 2011
DOI 10.1186/1756-9966-30-116
Pubmed ID
Authors

Yan-Wei Lin, Ji-Lin Wang, Hui-Min Chen, Yan-Jie Zhang, Rong-Lu, Lin-Lin Ren, Jie Hong, Jing-Yuan Fang

Abstract

Whether Folic acid is a potential drug that may prevent the progression of colorectal carcinoma and when to use are important healthy issues we focus on. Our study is to examine the effect of folic acid on the development of the CRC and the optimal time folic acid should be provided in a mouse-ICR model induced by 1, 2-Dimethylhydrazine. Also, we investigated the gene expression profile of this model related to folic acid.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 17%
Student > Master 2 17%
Researcher 2 17%
Student > Ph. D. Student 1 8%
Student > Bachelor 1 8%
Other 1 8%
Unknown 3 25%
Readers by discipline Count As %
Medicine and Dentistry 4 33%
Agricultural and Biological Sciences 2 17%
Nursing and Health Professions 1 8%
Immunology and Microbiology 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Other 0 0%
Unknown 3 25%